
Profitability, historical returns, and peer comparisons.
According to Neuland Laboratories Limited’s latest financial reports and current stock price. The company's current ROE is 24.47%. This represents a change of 303.20% compared to the average of 6.07% of the last 4 quarters.
The mean historical ROE of Neuland Laboratories Limited over the last ten years is 10.96%. The current 24.47% ROE has changed 123.33% with respect to the historical average. Over the past ten years (40 quarters), NEULANDLAB.NS's ROE was at its highest in in the March 2026 quarter at 11.35%. The ROE was at its lowest in in the March 2020 quarter at -1.31%.
Average
10.96%
Median
9.42%
Minimum
2.16%
Maximum
23.39%
Discovering the peaks and valleys of Neuland Laboratories Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 349.02%
Maximum Annual ROE = 23.39%
Minimum Annual Increase = -74.83%
Minimum Annual ROE = 2.16%
| Year | ROE | Change |
|---|---|---|
| 2026 | 19.42% | 13.84% |
| 2025 | 17.06% | -27.08% |
| 2024 | 23.39% | 42.22% |
| 2023 | 16.45% | 116.62% |
| 2022 | 7.59% | -25.94% |
| 2021 | 10.25% | 349.02% |
| 2020 | 2.28% | -2.88% |
| 2019 | 2.35% | 8.77% |
| 2018 | 2.16% | -74.83% |
| 2017 | 8.59% | -41.33% |
The current ROE of Neuland Laboratories Limited (NEULANDLAB.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.96%
5-year avg
16.78%
10-year avg
10.96%
Neuland Laboratories Limited’s ROE is less than Granules India Limited (13.78%), less than Alivus Life Sciences Limited (20.14%), less than Ipca Laboratories Limited (16.98%), less than NATCO Pharma Limited (12.80%), less than Aarey Drugs & Pharmaceuticals Limited (2.79%), less than Morepen Laboratories Limited (14.87%), less than Cohance Lifesciences Limited (2.74%), less than Orchid Pharma Limited (0.68%), less than Vasundhara Rasayans Limited (14.76%), less than Aarti Pharmalabs Limited (12.01%),
| Company | ROE | Market cap |
|---|---|---|
| 13.78% | $198.15B | |
| 20.14% | $181.77B | |
| 16.98% | $492.64B | |
| 12.80% | $158.31B | |
| 2.79% | $3.08B | |
| 14.87% | $50.55B | |
| 2.74% | $165.87B | |
| 0.68% | $44.02B | |
| 14.76% | $417.14M | |
| 12.01% | $84.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuland Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuland Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Neuland Laboratories Limited's ROE?
How is the ROE calculated for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the highest ROE for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 3-year average ROE for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 5-year average ROE for Neuland Laboratories Limited (NEULANDLAB.NS)?
How does the current ROE for Neuland Laboratories Limited (NEULANDLAB.NS) compare to its historical average?